Publications
Exposure to corticosteroids in pregnancy is associated with adverse perinatal outcomes among infants of mothers with inflammatory bowel disease: results from the PIANO registry. Odufalu FD, Long M, Lin K, Mahadevan U; PIANO Investigators from the Crohn's and Colitis Foundation (CCF) Clinical Research Alliance recruited patients for their respective centers for participant enrollment.Gut. 2022 Sep;71(9):1766-1772. doi: 10.1136/gutjnl-2021-325317
Vedolizumab Antagonizes MAdCAM-1-Dependent Human Placental Cytotrophoblast Adhesion and Invasion In Vitro. Blaisdell A, Zhou Y, Kattah MG, Fisher SJ, Mahadevan U.Inflamm Bowel Dis. 2022 Aug 1;28(8):1219-1228
Day Care Attendance and Infectious Complications in Children Born to Mothers With Inflammatory Bowel Disease. Long MD, Siegel CA, Abraham BP, Chiorean M, Mahadevan U. Clin Gastroenterol Hepatol. 2022 Mar;20(3):706-708
Pregnancy and Neonatal Outcomes After Fetal Exposure to Biologics and Thiopurines Among Women With Inflammatory Bowel Disease. Mahadevan U, Long MD, Kane SV, Roy A, Dubinsky MC, Sands BE, Cohen RD, Chambers CD, Sandborn WJ; Crohn's Colitis Foundation Clinical Research Alliance.Gastroenterology. 2021 Mar;160(4):1131-1139
Infliximab Use in a Child With Ulcerative Colitis and Prior In Utero Exposure to Infliximab. Lim J, Hammami MB, Mahadevan U.Gastroenterology. 2020 May;158(6):1834-1835
Safety of Flexible Sigmoidoscopy in Pregnant Patients with Known or Suspected Inflammatory Bowel Disease. Ko MS, Rudrapatna VA, Avila P, Mahadevan U.Dig Dis Sci. 2020 Oct;65(10):2979-2985
Preventive Health Care Among Postpartum Women With Inflammatory Bowel Disease: Results From the PIANO Registry. Mao EJ, Sheibani S, Martin C, Bloomfeld RS, Isaacs K, Saha S, Mahadevan U.Inflamm Bowel Dis. 2019 Mar 14;25(4):797-80
Inflammatory Bowel Disease in Pregnancy Clinical Care Pathway: A Report From the American Gastroenterological Association IBD Parenthood Project Working Group. Mahadevan U, Robinson C, Bernasko N, Boland B, Chambers C, Dubinsky M, Friedman S, Kane S, Manthey J, Sauberan J, Stone J, Jain R.Gastroenterology. 2019 Apr;156(5):1508-1524.
Exposure Concentrations of Infants Breastfed by Women Receiving Biologic Therapies for Inflammatory Bowel Diseases and Effects of Breastfeeding on Infections and Development. Matro R, Martin CF, Wolf D, Shah SA, Mahadevan U.Gastroenterology. 2018 Sep;155(3):696-704.
Anti-TNF and thiopurine therapy in pregnant IBD patients does not significantly alter a panel of B-cell and T-cell subsets in 1-year-old infants. Kattah MG, Milush JM, Burt T, McCabe RP Jr, Whang MI, Ma A, Mahadevan U.Clin Transl Gastroenterol. 2018 Apr 3;9(4):143.
Use of Biologic Therapy by Pregnant Women With Inflammatory Bowel Disease Does Not Affect Infant Response to Vaccines. Beaulieu DB, Ananthakrishnan AN, Martin C, Cohen RD, Kane SV, Mahadevan U.Clin Gastroenterol Hepatol. 2018 Jan;16(1):99-105. doi: 10.1016/j.cgh.2017.08.041
Inadequate Gestational Weight Gain Predicts Adverse Pregnancy Outcomes in Mothers with Inflammatory Bowel Disease: Results from a Prospective US Pregnancy Cohort. Bengtson MB, Martin CF, Aamodt G, Vatn MH, Mahadevan U.Dig Dis Sci. 2017 Aug;62(8):2063-2069
Inadequate Gestational Weight Gain, the Hidden Link Between Maternal IBD and Adverse Pregnancy Outcomes: Results from the Norwegian Mother and Child Cohort Study. Bengtson MB, Aamodt G, Mahadevan U, Vatn MH.Inflamm Bowel Dis. 2017 Jul;23(7):1225-1233
Vertical Transmission of Histoplasmosis Associated With Anti-Tumor Necrosis Factor Therapy. Carlucci JG, Halasa N, Creech CB, Dulek DE, Gómez-Duarte OG, Nelson GE, Talbot HK, Scalise ML, Scott PL, Mahadevan U, Beaulieu DB.J Pediatric Infect Dis Soc. 2016 Jun;5(2):e9-e12
Placental transfer of anti-tumor necrosis factor agents in pregnant patients with inflammatory bowel disease. Mahadevan U, Wolf DC, Dubinsky M, Cortot A, Lee SD, Siegel CA, Ullman T, Glover S, Valentine JF, Rubin DT, Miller J, Abreu MT.Clin Gastroenterol Hepatol. 2013 Mar;11(3):286-92;